longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Kingdomway

002626

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 37.60, within the reasonable range, cheaper than 31.03% of the time in the past 3 years, and the industry ranks 87/222, the industry Median 23.26.

37.6xP/E
¥16.19Stock price
¥0.43Earnings per share
37.6xP/E
Stock price¥16.19Earnings per share¥0.43

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
33.91x
Typical range
26.59x–44.41x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 23.26x
010203040

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 23.26x
0x40x80x120x160x200x
P/E ratio
Name/Symbol
600276SHHengrui Pharma
38.54x17.99%¥297.74B
600436SHZZPZH
39.15x4.02%¥70.83B
002422SZKELUN PHARMA
33.80x15.33%¥61.82B
600085SHTRT
33.00x7.45%¥32.01B
000739SZAPELOA
34.48x23.79%¥29.31B
600329SHDRTG
31.90x51.62%¥27.05B
600521SHHuahaipharm
37.87x305.56%¥23.78B
603456SHJiuzhou Pharma
24.20x12.93%¥14.32B
605507SHGuobang Pharma
20.04x--¥14.16B
603707SHNKF
25.77x11.11%¥12.44B
002019SZYifan Pharmaceutical
37.53x12.12%¥11.39B
600420SHSHYNDEC
20.22x--¥11.02B
600572SHCONBA
21.44x--¥10.69B
300357SZWolwo Pharma
25.03x18.88%¥10.45B
002626SZKingdomway
37.60x56.36%¥9.87B
688076SHSinopep
38.47x91.51%¥9.13B
688513SHEASTON BIOPHARMACEUTICALS
31.84x0.00%¥8.83B
300401SZGARDEN BIOPHARMA
31.59x56.86%¥8.70B
002332SZXJZY
22.07x5.56%¥8.52B
002550SZQianhong Bio-pharma
27.73x--¥8.14B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.